CompletedNot Applicable

Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients

China914 participantsStarted 2008-04

Plain-language summary

This open label, non-interventional study is to show the efficacy of Pulmicort®Respules® in cough variant asthma in patient aged 5-year old or younger in outpatient department

Who can participate

Age range5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Provision of informed consent * Patient who has been prescribed Pulmicort® Respules® according to physician's judgement, irrespective of the inclusion in the study. * The usage of Pulmicort® Respules® follows local authorised package insert. Exclusion Criteria: * Allergy to any ingredient of Pulmicort® Respules® * With history of Leukotriene Modifier (LM) usage prior to 2 weeks of recruitment or following plan. * Have used systemic/inhaled steroid prior to 2 weeks of recruitment

What they're measuring

Patient Symptom Score

Timeframe: 7 weeks (plus or minus 3 days )

Trial details

NCT IDNCT00660114

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2009-03

View on ClinicalTrials.gov More Cough Variant Asthma trials